Dina Domrös-Zoungrana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dina Domrös-Zoungrana has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Christian Lenz
Pfizer Pharma GmbH, Berlin, Germany
2 shared publicationsEmma Fröling
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication- Emma Fröling
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication - Johannes Nico Urban
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication - Klara Sonnie Hinrichsmeyer
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication Neda Rajaeean
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 11 September 2024
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 38 (5) , 331-342
Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities
The advent of artificial intelligence (AI) revolutionizes the ways of working in many areas of business and life science. In Medical Affairs (MA) departments of the pharmaceutical industry AI holds great potential for positively influencing the medical mission of identifying and addressing unmet medical needs and care gaps, and fostering solutions that improve the egalitarian and unbiased access of patients to treatments worldwide. Given the essential position of MA in corporate interactions with various healthcare stakeholders, AI offers broad possibilities to support strategic decision-making and to pioneer novel approaches in medical stakeholder interactions. By analyzing data derived from the healthcare environment and by streamlining operations in medical content generation, AI advances data-based prioritization and strategy execution. In this review, we discuss promising AI-based solutions in MA that support the effective use of heterogenous information from observations of the healthcare environment, the enhancement of medical education, and the analysis of real-world data. For a successful implementation of such solutions, specific considerations partly unique to healthcare must be taken care of, for example, transparency, data privacy, healthcare regulations, and in predictive applications, explainability.
- 11 September 2024
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 38 (5) , 331-342
Open AccessArtificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities
The advent of artificial intelligence (AI) revolutionizes the ways of working in many areas of business and life science. In Medical Affairs (MA) departments of the pharmaceutical industry AI holds great potential for positively influencing the medical mission of identifying and addressing unmet medical needs and care gaps, and fostering solutions that improve the egalitarian and unbiased access of patients to treatments worldwide. Given the essential position of MA in corporate interactions with various healthcare stakeholders, AI offers broad possibilities to support strategic decision-making and to pioneer novel approaches in medical stakeholder interactions. By analyzing data derived from the healthcare environment and by streamlining operations in medical content generation, AI advances data-based prioritization and strategy execution. In this review, we discuss promising AI-based solutions in MA that support the effective use of heterogenous information from observations of the healthcare environment, the enhancement of medical education, and the analysis of real-world data. For a successful implementation of such solutions, specific considerations partly unique to healthcare must be taken care of, for example, transparency, data privacy, healthcare regulations, and in predictive applications, explainability.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Medical Education: Considerations for a Successful Integration of Learning with and Learning about AI
Artificial intelligence (AI) with its diverse domains such as expert systems and machine learning already has multiple potential applications in medicine. Based on the latest developments in the multifaceted field of AI, it will play a pivotal role in medicine, with a high transformative potential in multiple areas, including drug development, diagnostics, patient care and monitoring. In the pharmaceutical industry AI is also rapidly gaining a crucial role. The introduction of innovative medicines requires profound background knowledge and the latest means of communication. This drives us to intensively engage with the topic of medical education, which is becoming more and more demanding due to the dynamic knowledge landscape, among other things, accelerated even more by digitalization and AI. Therefore, we argue for the incorporation of AI-based tools and methods in medical education, including personalized learning, diagnostic pathways, and data analysis, to prepare healthcare professionals for the evolving landscape of AI in medicine and support the fluency in dealing with AI by regular contact with various AI-based tools (Learning with AI). Understanding AI's vast potential and its caveats as well as gaining a basic knowledge of how AI works should be an important part of medical education to ensure that physicians can effectively and responsibly leverage AI-based systems in their daily practice and in scientific communication (Learning about AI).
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Open AccessMedical Education: Considerations for a Successful Integration of Learning with and Learning about AI
Artificial intelligence (AI) with its diverse domains such as expert systems and machine learning already has multiple potential applications in medicine. Based on the latest developments in the multifaceted field of AI, it will play a pivotal role in medicine, with a high transformative potential in multiple areas, including drug development, diagnostics, patient care and monitoring. In the pharmaceutical industry AI is also rapidly gaining a crucial role. The introduction of innovative medicines requires profound background knowledge and the latest means of communication. This drives us to intensively engage with the topic of medical education, which is becoming more and more demanding due to the dynamic knowledge landscape, among other things, accelerated even more by digitalization and AI. Therefore, we argue for the incorporation of AI-based tools and methods in medical education, including personalized learning, diagnostic pathways, and data analysis, to prepare healthcare professionals for the evolving landscape of AI in medicine and support the fluency in dealing with AI by regular contact with various AI-based tools (Learning with AI). Understanding AI's vast potential and its caveats as well as gaining a basic knowledge of how AI works should be an important part of medical education to ensure that physicians can effectively and responsibly leverage AI-based systems in their daily practice and in scientific communication (Learning about AI).